Try our mobile app
Screener
Company
Price and
change
Revenue Growth
last / hist
EV /
LTM
EBITDA
(p75)
EV/
Sales
EBITDA LTM
/ Revenue
FCF LTM
/ Revenue
Next GAAP report
Year div-d yield
FCF Yield LTM
0.0%  /
0.0%
>200x
>200x
5.7x
-200.0%
150.0%
2024-05-09
0.0%
25.0% 
-11.1%  /
73.0%
0.6x
1.4x
-7.8x
-1227.0%
134.5%
2024-05-09
0.0%
16 231.3% 
-28.6%  /
5.8%
>200x
>200x
5.3x
-75.0%
42.9%
2024-05-13
0.0%
6.7% 
4.1%  /
23.0%
56.1x
92.0x
5.7x
10.6%
39.6%
2024-05-07
0.0%
6.3% 
-15.4%  /
17.3%
6.3x
12.6x
3.2x
51.0%
26.5%
2024-08-12
1.7%
5.2% 
-0.8%  /
-6.8%
24.3x
16.3x
4.6x
19.0%
13.8%
2024-07-31
0.0%
3.1% 
12.8%  /
15.2%
31.6x
29.7x
8.0x
25.6%
12.6%
2024-08-09
0.8%
1.5% 
7.2%  /
14.2%
23.5x
30.9x
7.0x
30.4%
12.3%
2024-08-04
0.9%
1.8% 
11.5%  /
18.7%
60.4x
61.4x
17.7x
29.6%
10.2%
2024-07-20
0.0%
0.5% 
4.6%  /
5.4%
19.0x
19.2x
3.8x
20.2%
8.8%
2024-08-03
1.6%
2.8% 
-0.5%  /
5.8%
27.8x
18.6x
1.5x
5.4%
5.3%
2024-08-03
0.0%
4.4% 
9.3%  /
14.4%
22.4x
27.4x
5.8x
26.5%
4.9%
..
0.0%
1.0% 
-2.6%  /
9.0%
79.8x
174.0x
1.8x
2.3%
1.7%
..
2.1%
1.1% 
8.7%  /
10.0%
21.0x
27.3x
3.8x
18.3%
1.1%
2024-07-26
0.0%
0.3% 
11.0%  /
11.6%
>200x
>200x
2.1x
-4.9%
1.0%
2024-05-09
0.0%
0.5% 
23.8%  /
4.0%
23.3x
24.1x
4.9x
21.0%
1.0%
2024-05-09
0.0%
0.2% 
-69.0%  /
58.7%
0.4x
1.8x
0.2x
45.9%
0.9%
2024-05-13
0.0%
2.8% 
50.0%  /
27.8%
>200x
>200x
1.4x
-13.3%
0.0%
2024-05-09
0.0%
--- 
44.4%  /
18.4%
12.7x
13.8x
1.6x
12.5%
0.0%
..
0.0%
--- 
0.0%  /
0.0%
>200x
>200x
40.3x
-650.0%
0.0%
2024-05-14
0.0%
--- 
-17.5%  /
19.5%
131.5x
79.3x
13.9x
10.5%
0.0%
2024-08-02
0.0%
--- 
-1.6%  /
8.2%
8.3x
18.4x
1.1x
13.3%
0.0%
2024-07-27
3.2%
--- 
9.9%  /
20.8%
22.2x
33.3x
6.6x
23.2%
0.0%
2024-06-10
0.3%
--- 
0.0%  /
0.0%
>200x
>200x
10000.0x
0.0%
0.0%
..
0.0%
--- 
17.9%  /
9.4%
19.2x
23.2x
1.2x
6.4%
0.0%
2024-08-02
0.0%
--- 
0.0%  /
0.0%
1.5x
1.5x
-140.8x
0.0%
0.0%
2024-05-14
0.0%
-241.9% 
-3.1%  /
8.9%
13.2x
31.8x
9.3x
70.5%
0.0%
2024-07-27
0.2%
--- 
3.8%  /
6.1%
24.9x
21.0x
3.7x
15.1%
-4.5%
2024-08-03
0.7%
-1.4% 
0.0%  /
1.1%
39.8x
49.6x
1.7x
3.3%
-5.0%
2024-05-07
0.0%
-3.9% 
9.5%  /
25.3%
>200x
>200x
0.8x
-1.8%
-5.7%
..
0.0%
-8.2% 
17.2%  /
26.0%
>200x
45.8x
2.2x
-5.1%
-7.2%
2024-07-26
0.0%
-3.2% 
23.8%  /
29.1%
>200x
>200x
2.1x
-51.0%
-8.3%
2024-05-13
0.0%
-4.0% 
-40.9%  /
56.9%
>200x
>200x
5.8x
-46.0%
-9.7%
2024-05-09
0.0%
-1.6% 
1.8%  /
8.8%
22.5x
22.1x
5.0x
22.4%
-10.9%
2024-05-14
0.3%
-2.4% 
16.2%  /
17.1%
>200x
>200x
16.0x
-30.4%
-14.1%
2024-08-03
0.0%
-0.9% 
13.9%  /
0.3%
>200x
>200x
2.7x
-39.7%
-18.4%
2024-07-27
0.0%
-5.8% 
2.3%  /
5.9%
16.5x
23.1x
4.3x
27.1%
-30.6%
2024-05-06
2.0%
-7.1% 
37.9%  /
22.5%
2.1x
22.1x
-0.4x
-16.9%
-31.2%
2024-05-08
0.0%
0.0% 
66.7%  /
66.0%
>200x
>200x
8.0x
-35.5%
-38.7%
2024-05-13
0.0%
-4.6% 
0.0%  /
16.7%
>200x
>200x
3.5x
-80.0%
-50.0%
2024-05-14
0.0%
-11.1% 
78.8%  /
24.9%
30.6x
44.4x
4.2x
14.3%
-54.6%
2024-05-07
0.0%
-14.3% 
-0.4%  /
25.6%
17.1x
30.0x
1.7x
10.2%
-70.4%
2024-05-07
0.0%
-65.2% 
60.0%  /
13.5%
>200x
>200x
1.0x
-92.0%
-92.6%
..
0.0%
-3 000.0% 
0.0%  /
-2.8%
>200x
56.0x
4.6x
-62.5%
-275.0%
..
0.0%
-57.9% 
-7.7%  /
73.4%
0.8x
1.5x
-4.5x
-566.6%
-776.3%
2024-05-16
0.0%
-10 880.3% 
Trending screeners:
@electric-vehicles
@saas
@cannabis-players
@china
Latin America
India
Dividends
@REITs
@adtech
@airlines
@artificial-intelligence
@auto-parts
@cloud-computing
@crypto
@cybersecurity
@e-commerce
@edtech
@finance-and-technology
@gaming
@internet-of-things
@oil-refining
@real-estate-tech
@renewable-energy
@vaccine-makers

Reviews

2024-05-10
#reports #PODD

[Insulet](https://eninvs.com/all.php?name=PODD) (Medical equipment manufacturer) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=PODD&q=2024 q1&id=781050)
(2024-05-09, After Market Close):

- Revenue +23.5% YoY (vs +37.8% in previous quarter and historical rate +23.0%)
- EBITDA +76.3% YoY (vs +212.8% in previous quarter and historical rate +62.4%)
- EBITDA margin 15.2% increased compared to 10.6% same period last year
- Net Debt decreased by $62.0 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.0% of market cap
- EV/EBITDA multiple is 42.8x compared to historical level (75th percentile) of 171.2x
- EV/Sales multiple is 7.3x

2024-05-10
#reports #ORGO

[Organogenesis](https://eninvs.com/all.php?name=ORGO) (Drug Manufacturers — Specialty and Generic) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=ORGO&q=2024 q1&id=781043)
(2024-05-09, After Market Close):

- Revenue +1.9% YoY (vs -13.8% in previous quarter and historical rate +7.2%)
- EBITDA margin -0.9% has not changed compared to -0.9% same period last year
- Net Debt increased by $12.0 mln over the past reporting period (4.0% of market cap)
- FCF (LTM) +$0.0 bln (positive), 2.0% of market cap
- EV/EBITDA multiple is 13.6x compared to historical level (75th percentile) of 16.7x
- EV/Sales multiple is 0.7x

2024-05-10
#reports #NTRA

[Natera](https://eninvs.com/all.php?name=NTRA) (Medical services provider) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=NTRA&q=2024 q1&id=781040)
(2024-05-09, After Market Close):

- Revenue +52.1% YoY (vs +43.3% in previous quarter and historical rate +40.5%)
- EBITDA margin -19.0% increased compared to -55.4% same period last year
- Net Debt decreased by $6.0 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.8% of market cap
- EV/Sales multiple is 7.4x

2024-05-10
#reports #NKTR

[Nektar Therapeutics](https://eninvs.com/all.php?name=NKTR) (Medicines developer) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=NKTR&q=2024 q1&id=781039)
(2024-05-09, After Market Close):

- Revenue 0.0% YoY (vs +9.1% in previous quarter and historical rate -8.0%)
- EBITDA margin 9.1% increased compared to -440.9% same period last year
- Net Debt increased by $11.0 mln over the past reporting period (3.6% of market cap)
- FCF (LTM) -$0.2 bln (negative), 50.7% of market cap
- EV/Sales multiple is 1.4x

2024-05-10
#reports #MNTK

[Montauk Renewables, Inc.](https://eninvs.com/all.php?name=MNTK) (Utilities — Diversified) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=MNTK&q=2024 q1&id=781036)
(2024-05-09, After Market Close):

- Revenue +105.3% YoY (vs -44.0% in previous quarter and historical rate +43.9%)
- EBITDA margin 20.5% increased compared to -47.4% same period last year
- Net Debt increased by $8.0 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) -$0.0 bln (negative), 1.0% of market cap
- EV/EBITDA multiple is 5.2x compared to historical level (75th percentile) of 32.0x
- EV/Sales multiple is 3.4x

2024-05-10
#reports #MGNX

[MacroGenics](https://eninvs.com/all.php?name=MGNX) (Biotechnology) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=MGNX&q=2024 q1&id=781035)
(2024-03-07, After Market Close):

- Revenue -62.5% YoY (vs -84.9% in previous quarter and historical rate +10.5%)
- EBITDA margin -566.7% decreased compared to -150.0% same period last year
- Net Debt decreased by $184.0 mln over the past reporting period (20.3% of market cap)
- FCF (LTM) +$0.0 bln (positive), 1.3% of market cap
- EV/Sales multiple is 16.8x

At the opening of the session the share price went down -5.7% vs S&P500 +0.1%
2024-05-10
#reports #LCTX

[Lineage Cell Therapeutics](https://eninvs.com/all.php?name=LCTX) (Biotechnology) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=LCTX&q=2024 q1&id=781029)
(2024-05-09, After Market Close):

- Revenue -50.0% YoY (vs 0.0% in previous quarter and historical rate +61.1%)
- EBITDA margin -700.0% decreased compared to -350.0% same period last year
- Net Debt decreased by $7.0 mln over the past reporting period (3.5% of market cap)
- EV/Sales multiple is 23.0x

2024-05-10
#reports #LAW

[CS Disco, Inc.](https://eninvs.com/all.php?name=LAW) (Software — Application) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=LAW&q=2024 q1&id=781028)
(2024-05-09, After Market Close):

- Revenue +9.1% YoY (vs +9.1% in previous quarter and historical rate +18.3%)
- EBITDA margin -30.6% increased compared to -63.6% same period last year
- Net Debt increased by $10.0 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) -$0.0 bln (negative), 7.2% of market cap
- EV/Sales multiple is 2.4x

2024-05-10
#reports #KRT

[Karat Packaging Inc.](https://eninvs.com/all.php?name=KRT) (Packaging and Containers) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=KRT&q=2024 q1&id=781027)
(2024-05-09, After Market Close):

- Revenue 0.0% YoY (vs +3.2% in previous quarter and historical rate +10.9%)
- EBITDA -26.7% YoY (vs 0.0% in previous quarter and historical rate +31.8%)
- EBITDA margin 11.5% decreased compared to 15.6% same period last year
- Net Debt increased by $74.0 mln over the past reporting period (12.8% of market cap)
- FCF (LTM) +$0.0 bln (positive), 2.1% of market cap
- EV/EBITDA multiple is 12.9x compared to historical level (75th percentile) of 10.0x
- EV/Sales multiple is 1.5x

2024-05-10
#reports #KODK

[Eastman Kodak Company](https://eninvs.com/all.php?name=KODK) (Specialty Business Services) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=KODK&q=2024 q1&id=781025)
(2024-05-09, After Market Close):

- Revenue -10.4% YoY (vs -9.8% in previous quarter and historical rate +2.9%)
- Net Income -3.0% YoY (vs -28.6% in previous quarter and historical rate +24.9%)
- Net Income margin 12.9% increased compared to 11.9% same period last year
- P/E multiple is 5.0x compared to historical level (75th percentile) of 6.5x
- P/S multiple is 0.3x
- Price to book: 0.3x
2024-05-10
#reports #ISDR

[Issuer Direct Corporation](https://eninvs.com/all.php?name=ISDR) (Information Technology Services) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=ISDR&q=2024 q1&id=781024)
(2024-05-09, After Market Close):

- Revenue -22.2% YoY (vs +14.3% in previous quarter and historical rate +21.3%)
- EBITDA margin 14.3% increased compared to 11.1% same period last year
- Net Debt decreased by $1.0 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) +$0.0 bln (positive), 8.8% of market cap
- EV/EBITDA multiple is 11.9x compared to historical level (75th percentile) of 18.4x
- EV/Sales multiple is 1.8x

2024-05-10
#reports #III

[Information Services Group](https://eninvs.com/all.php?name=III) (Information Technology Services) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=III&q=2024 q1&id=781021)
(2024-05-09, After Market Close):

- Revenue -17.9% YoY (vs -10.8% in previous quarter and historical rate +4.2%)
- EBITDA -111.1% YoY (vs -128.6% in previous quarter)
- EBITDA margin -1.6% decreased compared to 11.5% same period last year
- EV/EBITDA multiple is 14.6x compared to historical level (75th percentile) of 14.3x
- EV/Sales multiple is 0.6x

2024-05-10
#reports #IAS

[Integral Ad Science Holding Corp.](https://eninvs.com/all.php?name=IAS) (Advertising Agencies) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=IAS&q=2024 q1&id=781020)
(2024-05-09, After Market Close):

- Revenue +8.5% YoY (vs +14.5% in previous quarter and historical rate +18.9%)
- EBITDA -27.3% YoY (vs +55.0% in previous quarter and historical rate +36.6%)
- EBITDA margin 13.9% decreased compared to 20.8% same period last year
- Net Debt increased by $9.0 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 6.0% of market cap
- EV/EBITDA multiple is 21.4x compared to historical level (75th percentile) of 43.0x
- EV/Sales multiple is 2.9x

2024-05-10
#reports #HQI

[HireQuest](https://eninvs.com/all.php?name=HQI) (Staffing and Employment Services) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=HQI&q=2024 q1&id=781018)
(2024-05-09, After Market Close):

- Revenue -20.0% YoY (vs +25.0% in previous quarter and historical rate +58.1%)
- EBITDA -25.0% YoY (vs -78.6% in previous quarter and historical rate +41.6%)
- EBITDA margin 37.5% decreased compared to 40.0% same period last year
- Net Debt increased by $1.0 mln over the past reporting period (0.6% of market cap)
- EV/EBITDA multiple is 15.9x compared to historical level (75th percentile) of 14.6x
- EV/Sales multiple is 5.3x

2024-05-10
#reports #HCAT

[Health Catalyst](https://eninvs.com/all.php?name=HCAT) (Software provider) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=HCAT&q=2024 q1&id=781017)
(2024-05-09, After Market Close):

- Revenue +1.4% YoY (vs +8.7% in previous quarter and historical rate +15.0%)
- EBITDA margin -16.0% increased compared to -32.4% same period last year
- Net Debt decreased by $10.0 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) -$0.0 bln (negative), 0.8% of market cap
- EV/Sales multiple is 1.0x

2024-05-10
#dividend #ABR

Arbor Realty Trust will pay dividends in the amount of 0.43 USD per share on 2024-05-15, which is 3.3% of the current price 12.84. Together with previous payments, the annual dividend yield will be 13.4%

(2024-02-29: 0.43 USD)
(2023-11-15: 0.43 USD)
(2023-08-11: 0.43 USD)
2024-05-10
#dividend #BRDG

Bridge Investment Group Holdings Inc. will pay dividends in the amount of 0.12 USD per share on 2024-05-30, which is 1.7% of the current price 6.94. Together with previous payments, the annual dividend yield will be 7.6%

(2024-03-06: 0.07 USD)
(2023-11-29: 0.17 USD)
(2023-08-30: 0.17 USD)
2024-05-10
#dividend #GSBD

Goldman Sachs BDC will pay dividends in the amount of 0.45 USD per share on 2024-06-27, which is 2.9% of the current price 15.63. Together with previous payments, the annual dividend yield will be 11.5%

(2024-03-26: 0.45 USD)
(2023-12-27: 0.45 USD)
(2023-09-27: 0.45 USD)
2024-05-10
#dividend #HTGC

Hercules Capital will pay dividends in the amount of 0.08 USD per share on 2024-05-10, which is 0.4% of the current price 19.86. Together with previous payments, the annual dividend yield will be 7.7%

(2024-02-26: 0.48 USD)
(2023-11-13: 0.48 USD)
(2023-08-16: 0.48 USD)
2024-05-10
#dividend #IEP

Icahn Enterprises will pay dividends in the amount of 1 USD per share on 2024-05-16, which is 5.5% of the current price 18.03. Together with previous payments, the annual dividend yield will be 22.2%

(2024-03-07: 1 USD)
(2023-11-15: 1 USD)
(2023-08-16: 1 USD)
2024-05-10
#dividend #NUS

Nu Skin Enterprises will pay dividends in the amount of 0.06 USD per share on 2024-05-30, which is 0.5% of the current price 12.78. Together with previous payments, the annual dividend yield will be 7.0%

(2024-02-22: 0.06 USD)
(2023-11-21: 0.39 USD)
(2023-08-23: 0.39 USD)